Avelumab (anti-PD-L1)

目录号：A2015 批次号: A201503

Avelumab (anti-PD-L1) (MSB0010718C) 是一种完全人IgG1单克隆抗体，靶向 protein programmed death-ligand 1 (PD-L1)。Avelumab 具有潜在的抗体依赖性细胞介导的细胞毒性作用，可用于多种癌症的治疗。MW=143.8 kDa。

抗体信息

CAS号	1537032-82-8
配制	PBS buffer, pH 7.2
推荐同型对照	Human IgG1
来源	Human
储存条件 (自收到货起)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
纯度	99.82%
蛋白浓度	3mg/ml
内毒素	＜1EU/mg

客户使用selleck产品的实验数据

Avelumab (anti-PD-L1)在文献中得到引用

TNF-Mediated Inhibition of Classical Swine Fever Virus Replication Is IRF1-, NF-κB- and JAK/STAT Signaling-Dependent [ Viruses, 2021, 13(10)2017]	PubMed: 34696447

TNF-Mediated Inhibition of Classical Swine Fever Virus Replication Is IRF1-, NF-κB- and JAK/STAT Signaling-Dependent [ Viruses, 2021, 13(10)2017]

PubMed: 34696447

禁止用于人体及治疗！